NR3C1 and acute lymphoblastic leukemia: Abnormal <i>NR3C1</i> transcription and/or translation is strongly associated with GC resistance, but the underlying molecular mechanism and the clinical value of NR3C1 alterations with GC resistance in ALL treatment remain unclear.